Literature DB >> 29880609

Loss of DEP-1 (Ptprj) promotes myeloproliferative disease in FLT3-ITD acute myeloid leukemia.

Anne Kresinsky1, Reinhard Bauer1, Tina M Schnöder2,3, Tobias Berg4, Daria Meyer5, Volker Ast5, Rainer König5, Hubert Serve4, Florian H Heidel2,3, Frank-D Böhmer1, Jörg P Müller6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29880609      PMCID： PMC6278956          DOI： 10.3324/haematol.2017.185306

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis.

Authors:  Francesco Trapasso; Alessandra Drusco; Stefan Costinean; Hansjuerg Alder; Rami I Aqeilan; Rodolfo Iuliano; Eugenio Gaudio; Cinzia Raso; Nicola Zanesi; Carlo M Croce; Alfredo Fusco
Journal:  DNA Cell Biol       Date:  2006-06       Impact factor: 3.311

2.  NFATc1 as a therapeutic target in FLT3-ITD-positive AML.

Authors:  S K Metzelder; C Michel; M von Bonin; M Rehberger; E Hessmann; S Inselmann; M Solovey; Y Wang; K Sohlbach; C Brendel; T Stiewe; J Charles; A Ten Haaf; V Ellenrieder; A Neubauer; S Gattenlöhner; M Bornhäuser; A Burchert
Journal:  Leukemia       Date:  2015-04-14       Impact factor: 11.528

3.  Cell transformation by FLT3 ITD in acute myeloid leukemia involves oxidative inactivation of the tumor suppressor protein-tyrosine phosphatase DEP-1/ PTPRJ.

Authors:  Rinesh Godfrey; Deepika Arora; Reinhard Bauer; Sabine Stopp; Jörg P Müller; Theresa Heinrich; Sylvia-Annette Böhmer; Markus Dagnell; Ulf Schnetzke; Sebastian Scholl; Arne Östman; Frank-D Böhmer
Journal:  Blood       Date:  2012-03-20       Impact factor: 22.113

4.  Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases.

Authors:  Dirk-E Schmidt-Arras; Annette Böhmer; Boyka Markova; Chunaram Choudhary; Hubert Serve; Frank-D Böhmer
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

5.  Protein-tyrosine phosphatase DEP-1 controls receptor tyrosine kinase FLT3 signaling.

Authors:  Deepika Arora; Sabine Stopp; Sylvia-Annette Böhmer; Julia Schons; Rinesh Godfrey; Kristina Masson; Elena Razumovskaya; Lars Rönnstrand; Simone Tänzer; Reinhard Bauer; Frank-D Böhmer; Jörg P Müller
Journal:  J Biol Chem       Date:  2011-01-24       Impact factor: 5.157

6.  Loss of the wild-type allele contributes to myeloid expansion and disease aggressiveness in FLT3/ITD knockin mice.

Authors:  Li Li; Emily Bailey; Sarah Greenblatt; David Huso; Donald Small
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

7.  Prognostically useful gene-expression profiles in acute myeloid leukemia.

Authors:  Peter J M Valk; Roel G W Verhaak; M Antoinette Beijen; Claudia A J Erpelinck; Sahar Barjesteh van Waalwijk van Doorn-Khosrovani; Judith M Boer; H Berna Beverloo; Michael J Moorhouse; Peter J van der Spek; Bob Löwenberg; Ruud Delwel
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

8.  Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor.

Authors:  K-F Tse; J Allebach; M Levis; B D Smith; F D Bohmer; D Small
Journal:  Leukemia       Date:  2002-10       Impact factor: 11.528

9.  An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.

Authors:  Klaus H Metzeler; Manuela Hummel; Clara D Bloomfield; Karsten Spiekermann; Jan Braess; Maria-Cristina Sauerland; Achim Heinecke; Michael Radmacher; Guido Marcucci; Susan P Whitman; Kati Maharry; Peter Paschka; Richard A Larson; Wolfgang E Berdel; Thomas Büchner; Bernhard Wörmann; Ulrich Mansmann; Wolfgang Hiddemann; Stefan K Bohlander; Christian Buske
Journal:  Blood       Date:  2008-08-20       Impact factor: 22.113

10.  FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia.

Authors:  Benjamin H Lee; Zuzana Tothova; Ross L Levine; Kristina Anderson; Natalija Buza-Vidas; Dana E Cullen; Elizabeth P McDowell; Jennifer Adelsperger; Stefan Fröhling; Brian J P Huntly; Miloslav Beran; Sten Eirik Jacobsen; D Gary Gilliland
Journal:  Cancer Cell       Date:  2007-10       Impact factor: 31.743
View more
  2 in total

1.  The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia.

Authors:  Jifu Zheng; Yuan Song; Zhenjiang Li; Aiping Tang; Yan Fei; Wenfeng He
Journal:  Cancer Med       Date:  2019-09-30       Impact factor: 4.452

2.  iTRAQ plasma proteomics analysis for candidate biomarkers of type 2 incipient diabetic nephropathy.

Authors:  Hongmei Lu; Shaodong Deng; Minghui Zheng; Kunhua Hu
Journal:  Clin Proteomics       Date:  2019-07-31       Impact factor: 3.988
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.